S. 1930: Small Biotech Innovation Act

S. 1930 is a federal bill in the 119th Congress. Before this bill, certain single source drugs made by small biotechnology companies were subject to the Medicare drug price negotiation program starting in 2029. After this bill takes effect, qualifying small biotechnology companies that spend a specific… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.